Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Miller, B. | Heilmann, L.
Affiliations: Department of Obstetrics and Gynecology, Universityhospital Essen, Hufelandstr. 55, 4300 Essen 1, FRG
Note: [] Accepted by: Editor H. Hartert
Abstract: 25 patients with breast cancer after primary surgery and 10 patients with metastatic disease were investigated regarding hemorheological parameters such as erythrocyte aggregation, plasma viscosity, hematocrit and fibrinogen during chemotherapy with methotrexate, 5-fluorouracil and cyclophosphamide. Erythrocyte aggregation increased significantly during the first course of chemotherapy and remained elevated thereafter. There were no significant changes regarding the other parameters. The influence of tumor volume was much more important leading to significant differences between the two groups regarding erythrocyte aggregation, plasma viscosity and fibrinogen, while hematocrit and total protein concentration were not different.
Keywords: breast cancer, chemotherapy, hemorheology
DOI: 10.3233/CH-1987-7214
Journal: Clinical Hemorheology and Microcirculation, vol. 7, no. 2, pp. 287-293, 1987
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl